0001209191-23-019078.txt : 20230315 0001209191-23-019078.hdr.sgml : 20230315 20230315210020 ACCESSION NUMBER: 0001209191-23-019078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230313 FILED AS OF DATE: 20230315 DATE AS OF CHANGE: 20230315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAYS F BARRY CENTRAL INDEX KEY: 0001183554 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 23736877 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 471052611 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-03-13 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001183554 BAYS F BARRY C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 1 0 0 0 Common Stock 2023-03-13 4 S 0 8320 24.0731 D 1273963 D Common Stock 2023-03-13 4 S 0 1080 24.7305 D 1272883 D Common Stock 2023-03-14 4 S 0 9400 23.2482 D 1263483 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.6300 to $24.5200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.6300 to $24.9000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.0400 to $23.6250 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Lisa Taylor as Attorney-in-fact for F. Barry Bays 2023-03-15